Delving into the Latest Updates on Dawei (Anhui) Pharmaceutical Co., Ltd. with Synapse

Overview

研究空腹与餐后状态下单次口服受试制剂（布洛芬混悬液，规格100mL:2g，大玮（安徽）药业有限公司持证）参比制剂（布洛芬混悬液，规格100mL:2g，商品名：美林，上海强生制药有限公司持证）在健康受试者体内的药代动力学特征，比较受试制剂与参比制剂的生物等效性，并研究药物在健康受试者体内的安全性

[Translation]

To study the pharmacokinetic characteristics of a single oral dose of the test preparation (ibuprofen suspension, specification 100mL:2g, licensed by Dawei (Anhui) Pharmaceutical Co., Ltd.) and the reference preparation (ibuprofen suspension, specification 100mL:2g, trade name: Meilin, licensed by Shanghai Johnson Pharmaceutical Co., Ltd.) in healthy subjects under fasting and postprandial conditions, to compare the bioequivalence of the test preparation and the reference preparation, and to study the safety of the drug in healthy subjects

Start Date-

Sponsor / Collaborator

Dawei (Anhui) Pharmaceutical Co., Ltd.

100 Clinical Results associated with Dawei (Anhui) Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Dawei (Anhui) Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Dawei (Anhui) Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Dawei (Anhui) Pharmaceutical Co., Ltd.

Login to view more data